Business · 13/12/20001 min read
FDA Reopens Comment Period for Human Bone Allograft Meeting
The FDA is extending the comment period for a public meeting on human bone allografts for 60 days, allowing more time for public input on orthopedic reconstruction and repair issues
Original source language: Federal Register — Food and Drug AdministrationOpen original release →